Connect with us

Technology

Calyx and Invicro agree to combine to create a global leader in medical imaging and software solutions for the clinical research community

Published

on

LONDON and BOSTON, March 7, 2024 /PRNewswire/ — Calyx, a leading technology-enabled provider of Medical Imaging services and IRT/RTSM (Interactive Response Technology/Randomised Trial Supply Management) to drug developers, and Invicro, a next-generation quantitative imaging biomarker company and pre-eminent development partner to pharma sponsors, have agreed to combine their business. This complementary combination will create a new global leader in the provision of medical imaging solutions and development services to the clinical research community.

Union to create a truly differentiated industry leader and provide broader imaging support in response to customer needs

The enlarged Group (“Group”) formed through this strategic combination will see 100% of Invicro being acquired by Calyx from its current owner, REALM IDx, Inc. The transaction is subject to regulatory filings and customary closing conditions and is expected to complete in Q2 2024.

Calyx and Invicro each provide complementary services to most of the world’s leading pharma and biotechnology companies. The Group will employ approximately 2,000 highly skilled employees across ten sites, throughout the US, Europe and Asia, thereby having the ability to provide a full suite of solutions to its clients across the world. The combination unites deep heritage and extensive experience reflected in combined support for almost 12,000 clinical and research trials to date, across all clinical phases, including oncology and the central nervous system (CNS). The Group will also boast deep research and development capabilities to provide scientific and service support in the preclinical and exploratory work of its clients.

Commenting on the transaction, David Herron, CEO of Calyx, said: “Calyx and Invicro are uniquely complementary businesses in terms of their scientific talent, service offerings, and international presence. This exciting union will create a truly differentiated industry leader and provides a clear response to growing customer requirements for broader support. Our leadership will be evident in terms of the Group’s global reach across the US, Europe and Asia, and, critically, our extensive scientific knowledge, capabilities and experience. This combined expertise and broader best-in-class specialist support creates a compelling customer proposition for the greater biopharma industry, ranging from large pharma companies to speciality biotech firms. This spans the complete R&D lifecycle from discovery through research and development to post-marketing, across a number of areas including imaging biomarkers, core lab services, analytics and software.”

Edward Hogan, COO of Invicro, said: “We are very excited about the impending combination of our two companies. We see huge opportunity in uniting highly skilled teams of scientists and researchers to enable us to work more closely with our partners. Our work will help accelerate the development of new life-saving therapies to provide better outcomes for patients.  We can do this across key therapeutic areas, including oncology and the central nervous system (CNS), including unique specialist radioligand therapy capabilities to meet the growing demand for enhanced imaging and new treatments in fast-growing specialities such as radiotherapy, gastroenterology, inflammation, fibrosis and mitochondrial imaging.”

Post completion of the transaction, the process to combine and integrate the two companies will commence. During this period the focus will be on ensuring that customers receive the same high-quality service and support that they have been accustomed to receiving from both Calyx and Invicro.

For further information please contact: 

Paul Griffin
Reputation Inc
pgriffin@reputation-inc.com
+353 87 667 4305

Christine Tobin
Calyx
Christine.Tobin@Calyx.ai
+1 412-628-8598

About Calyx
Calyx is a leading global technology-enabled service provider for medical imaging and IRT/RTSM (Interactive Response Technology/Randomised Trial Supply Management) for drug developers and the global clinical research community. Calyx’s market-leading service, scientific knowledge, expertise and technology offering helps speed up the delivery of life-saving treatments to millions of patients around the world by accelerating and improving clinical trial outcomes. With operations in six countries, the company provides 24/7 services to most of the world’s leading pharma and biotech companies.

About Invicro
Headquartered in the US, Invicro is a next-generation quantitative imaging biomarker company focused on accelerating the discovery and development of life-changing medicines. With laboratories in the US, UK, India, Japan and China, Invicro is global research partner to numerous pharmaceutical, biotech and contract research organizations, leveraging its platform to combine best-in-class expertise, imaging biomarkers, core lab services, analytics, and software. Its medical imaging capabilities are helping to achieve better patient outcomes in key therapeutic areas including oncology, central nervous system and respiratory, as well as meet the growing demand for enhanced imaging and new therapies in fast-growing specialities such as radiotherapy, gastroenterology, inflammation, fibrosis and mitochondrial imaging.

View original content to download multimedia:https://www.prnewswire.com/news-releases/calyx-and-invicro-agree-to-combine-to-create-a-global-leader-in-medical-imaging-and-software-solutions-for-the-clinical-research-community-302082182.html

SOURCE Calyx

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MagFone Christmas & New Year Sale: Unbeatable Discounts for the Holiday Season

Published

on

By

The festive season is upon us, and MagFone is here to make your holidays even brighter with an exclusive Christmas & New Year sale! From incredible discounts on best-selling products to special deals on new products, MagFone is the ultimate destination for holiday shopping. From December 18, 2024 to January 6, 2025, this sale offers up to 80% off discount for everyone. Let’s dive into the details of the most awaited sale of the year.

HONGKONG, Dec. 21, 2024 /PRNewswire-PRWeb/ — What Can You Get from MagFone Christmas & New Year Sale?

New arrival – Location Changer is only $1.99 to everyone in this MagFone Christmas & New Year Grand sales. Moreover, everyone can enjoy up to 80% OFF.

1. Best-Selling Products at Up to 70% OFF

Resolving various iOS system issues or unlocking locked Apple devices like iPhone and iPad by yourself at home with MagFone’s flagship products, now available at unbeatable prices. Best-selling products such as iPhone Unlocker, Activation Unlocker, and iOS System Recovery are up for grabs with discounts of up to 70% off. Don’t miss out on this chance to get MagFone’s best-selling products at jaw-dropping prices.

MagFone iPhone Unlocker at $20.95/month and $41.95/lifetime.MagFone Activation Unlocker at $20.95/month and $41.95/lifetime.MagFone iOS System Recovery at $17.95/month and $48.95/lifetime.

2. New Arrival to Get with Only $1.99

Whether you want to change your location on your mobile device or simulate GPS movement in various games, MagFone’s new product – Location Changer – is perfect for you. Designed for both iOS and Android users, this tool comes equipped with advanced location changing features, flexible movement speed, and customizable route. With only $1.99, it is a must-have for this Christmas sale if you have the demand to change your device location.

3. 4-in-1 Bundle to Maximize Your Savings

MagFone values all loyal customers and offers exclusive pers during the Christmas & New Year sale. A super 4-in-in bundle is at reduced prices, which enables you to get all products from MagFone with an 80% off discount. This bundle includes all the tools you need, whether you’re looking to resolve various system problems and unlocking issues or change iPhone and Android device’s location. Don’t miss this chance to get all MagFone products at unbeatable prices.

MagFone Christmas & New Year Sale is a limited-time event, running from December 18, 2024 to January 6, 2025. With discount this good, products are expected to get at the lowest price this year. Don’t wait until the last minute—start shopping now to get MagFone products at the best deals.

About MagFone:

MagFone is redefining tech innovation with state-of-the-art technology and intuitive design. Whether their flagship products like iPhone Unlocker or newly-released tools like Location Changer, MagFone products are built for performance and flexibility.

YouTube: https://www.youtube.com/@magfone

Facebook: https://www.facebook.com/magfone/

X: https://x.com/magfone

Media Contact

Olivia Wood, MagFone, 86 19186985874, support@magfone.com, https://www.magfone.com/

View original content to download multimedia:https://www.prweb.com/releases/magfone-christmas–new-year-sale-unbeatable-discounts-for-the-holiday-season-302337015.html

SOURCE MagFone

Continue Reading

Technology

Dr. Ashley Milhizer Sees 300% Growth in 2024 at Real Results Medical & Aesthetics

Published

on

By

After nearly two years in business, Dr. Ashley Milhizer’s Tempe-based center for naturopathic medicine and aesthetics has experienced the type of growth that rival industry titans. Real Results Medical & Aesthetics – soon to be opening a second location in Scottsdale in early 2025 – has seen an impressive 300% growth since opening their doors in March 2023.

TEMPE, Ariz., Dec. 21, 2024 /PRNewswire-PRWeb/ — After nearly two years in business, Dr. Ashley Milhizer’s Tempe-based center for naturopathic medicine and aesthetics has experienced the type of growth that rival industry titans. Real Results Medical & Aesthetics – soon to be opening a second location in Scottsdale in early 2025 – has seen an impressive 300% growth since opening their doors in March 2023.

Aside from patient referrals and cutting-edge technology, Milhizer credits social media as one of the biggest avenues for growth. “Between TikTok and Instagram we’ve amassed over 25,000 followers and that accounts for about 70% of our new business.”

Aside from patient referrals and cutting-edge technology, Milhizer credits social media as one of the biggest avenues for growth. “Between TikTok and Instagram we’ve amassed over 25,000 followers and that accounts for about 70% of our new business,” said Dr. Ashley Milhizer, Founder of Real Results Medical & Aesthetics.

On both platforms, Dr. Milhizer shares educational videos and insights into various medical & aesthetic procedures. Her engaging content not only highlights the quality of care she provides but also educates her audience on the latest trends and treatments in the field.

Originally from Michigan, and a graduate of UC Davis and the Southwest College of Naturopathic Medicine & Health Sciences, it was Dr. Milhizer’s personal experience in seeing how natural remedies can significantly impact the body that inspired her to get into the field.

“While I was in school, a friend of mine was diagnosed with stage 3 cancer and was given up to 18 months to live and I became determined to research every kind of remedy that could potentially help,” said Dr. Milhizer. “From a healthy diet, supplements and a host of other naturopathic strategies, we tried everything we could find and two months later he was in remission, and he’s still alive today.”

The power of naturopathic remedies, following an early career path in sports medicine – which enabled her to work with some of the state’s top professional athletes – is what led her to forming Real Results Medical & Aesthetics. The company’s broad depth of services is also what allowed her to expand her reach of clientele beyond athletes to everyone from the Valley’s elite CEOs and stay at home Moms to patients ranging from their early 20s to upper 80s.

The naturopathic services offered at Real Results Medical & Aesthetics include hormone optimization, peptide therapy, IV therapy, natural pain relief, weight loss, food allergy testing and overall diagnostic testing. While the aesthetics side of the business offers services such as hair restoration, skin resurfacing, botox, fillers, microneedling, RF Plasma skin resurfacing, laser treatments, vein removal and body contouring.

For more information on Real Results Medical & Aesthetics, visit www.realresultsmedical.com or call/text 480.245.5636. For ongoing news, updates and service offerings, follow Dr. Milhizer on Facebook, Instagram and LinkedIn.

Media Contact

Kendra Riley, Real Results Medical & Aesthetics, 1 4802206051, kendra@dawningpr.com 

View original content to download multimedia:https://www.prweb.com/releases/dr-ashley-milhizer-sees-300-growth-in-2024-at-real-results-medical–aesthetics-302337009.html

SOURCE Real Results Medical & Aesthetics

Continue Reading

Technology

ICEYE expands its Earth Observation capabilities with launch of two SAR satellites for mid-inclination orbit on the Bandwagon-2 mission with SpaceX

Published

on

By

Mid-inclination orbit provides more SAR-imaging opportunities at middle latitudes of the globe for ICEYE customers.

HELSINKI, Finland, Dec. 21, 2024 /PRNewswire/ — ICEYE, the global leader in SAR satellite operations for Earth Observation and persistent monitoring, announced today that it has launched two new satellites to its constellation of SAR satellites. Both satellites expand the availability of ICEYE’s latest imaging technology to deliver additional 25 cm imaging capacity. The satellites were integrated via Exolaunch and launched as part of the Bandwagon-2 rideshare mission with SpaceX from Vandenberg Space Force Base in California, USA. Both satellites have established communication, and early routine operations are underway. With today’s launch, ICEYE has successfully launched 40 satellites into orbit since 2018, with nine satellites launched in 2024 alone.

The new SAR satellites were launched into mid-inclination orbits; compared to a polar orbit, these mid-inclination orbits provide more than twice the collection opportunities at middle latitudes of the globe. ICEYE customers have many areas of interest in these middle latitudes (+/- 45 degrees), and these customers will benefit from increased persistence over these regions. Customers with imaging interests outside these middle latitudes will continue to benefit from the frequent revisit enabled by ICEYE’s dozens of satellites in polar orbits. ICEYE’s unique mix of mid-inclination and polar orbits provides its customers with deep revisit capabilities for targets all around the globe. The new satellites will serve ICEYE’s commercial missions as part of the world’s largest SAR satellite constellation owned and operated by ICEYE.

Rafal Modrzewski, CEO and Co-founder of ICEYE said: “This launch marks another significant milestone in ICEYE’s ability to provide our customers with a rich diversity of collection opportunities. We bolster our industry-leading SAR constellation and expand our customers’ collection opportunities in the areas most important to them.”

Today’s launch is another step forward in ICEYE’s steady drumbeat of innovative breakthroughs in Earth Observation. This year alone, ICEYE has, for example, introduced Dwell Precise, a new 25 cm imaging mode that offers its customers the highest-fidelity 25cm imaging capability, and adds advanced capability to ICEYE’s line of Dwell products; launched an API that allows customers to directly task its SAR satellite constellation; and launched ICEYE Ocean Vision to provide actionable intelligence for maritime domain awareness.

About ICEYE

ICEYE delivers unparalleled persistent monitoring capabilities to detect and respond to changes in any location on Earth, faster and more accurately than ever before.

Owning the world’s largest synthetic aperture radar (SAR) satellite constellation, ICEYE provides objective, near real-time insights, ensuring that customers have unmatched access to actionable high-quality data, day or night, even in challenging environmental conditions. As a trusted partner to governments and commercial industries, ICEYE delivers intelligence in sectors such as insurance, natural catastrophe response and recovery, security, maritime monitoring, and finance, enabling decision-making that contributes to community resilience and sustainable development.

ICEYE operates internationally with offices in Finland, Poland, Spain, the UK, Australia, Japan, UAE, Greece, and the US.  We have more than 700 employees, inspired by the shared vision of improving life on Earth by becoming the global source of truth in Earth Observation.

Media contact: press@iceye.com

Visit www.iceye.com and follow ICEYE on LinkedIn and X for the latest updates and insights.

View original content to download multimedia:https://www.prnewswire.com/news-releases/iceye-expands-its-earth-observation-capabilities-with-launch-of-two-sar-satellites-for-mid-inclination-orbit-on-the-bandwagon-2-mission-with-spacex-302337876.html

SOURCE ICEYE

Continue Reading

Trending